| Not Yet Recruiting | Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqN Squamous NSCLC | Phase 1 | 2025-07-30 |
| Completed | Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma Glioblastoma | Phase 1 | 2023-06-01 |
| Completed | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults Influenza | Phase 1 | 2022-02-07 |
| Withdrawn | A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Comp Coronavirus, Covid19, SARS-CoV-2 | Phase 3 | 2021-10-01 |
| Terminated | COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV Coronavirus, Covid19, SARS-CoV-2 | Phase 3 | 2021-04-22 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 Coronavirus, Covid19, SARS-CoV-2 | Phase 3 | 2020-12-23 |
| Completed | A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Effi Covid19, SARS-CoV-2 | Phase 2 / Phase 3 | 2020-12-11 |
| Completed | A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healt Coronavirus, Covid19, SARS-CoV-2 | Phase 2 | 2020-09-21 |
| Completed | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVI Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2 | Phase 1 | 2020-06-18 |
| Completed | A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Rabies | Phase 1 | 2018-10-12 |
| Unknown | Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck | Phase 1 | 2017-09-25 |
| Completed | Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults Rabies | Phase 1 | 2014-09-01 |
| Terminated | An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Pr Prostate Carcinoma | Phase 2 | 2014-06-01 |
| Completed | RNActive® Rabies Vaccine (CV7201) in Healthy Adults Rabies | Phase 1 | 2013-10-01 |
| Terminated | Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC Non-Small Cell Lung Carcinoma | Phase 1 | 2013-04-01 |
| Terminated | Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2012-08-01 |
| Completed | Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease Hormonal Refractory Prostate Cancer | Phase 1 / Phase 2 | 2009-01-01 |